Senti Biosciences Appoints Deborah Knobelman as Chief Financial Officer
Senti Biosciences announced Deborah Knobelman, was appointed Chief Financial Officer, effective May 19, 2021. Deborah brings over 20 years of experience most recently, serving in interim C-Suite roles for numerous life sciences companies and, before that, as CFO for Zeno Health (formerly GeneriCo) and CBO for Ampio Pharmaceuticals Inc.
Senti Biosciences is a team of engineers, scientists, and entrepreneurs on a mission to leverage synthetic biology to treat the most pressing diseases. It is privately held and based in San Francisco, CA.